| 注册
首页|期刊导航|医学信息|酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察

酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察

文永胜

医学信息2016,Vol.29Issue(7):117-118,2.
医学信息2016,Vol.29Issue(7):117-118,2.

酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察

Phentolamine and Pituitrin Combined Treatment of Pulmonary Tuberculosis Hemoptysis Clinical Curative Effect and Safety Observation

文永胜1

作者信息

  • 1. 四川省广元市苍溪县人民医院﹐四川 广元 628400
  • 折叠

摘要

Abstract

Objective Discussion joint phentolamine,vasopressin treatment of tuberculosis hemoptysis efficacy,safety. Methods The 122 cases of lung tuberculosis patients were divided into a control group (vasopressin treatment),the observation group (vasopressin joint phentolamine treatment), efficacy and safety. Results The total effective rate (95.4%VS78.9%),incidence of adverse reactions (6.2%VS26.3%), <0.05.Conclusion Phentolamine,vasopressin combined method of treatment of tuberculosis hemoptysis significant effect,safe.

关键词

肺结核咯血/酚妥拉明/垂体后叶素/疗效

Key words

Tuberculosis hemoptysis/Phentolamine/Vasopressin/Efficacy

引用本文复制引用

文永胜..酚妥拉明和垂体后叶素联合法治疗肺结核咯血临床疗效和安全性观察[J].医学信息,2016,29(7):117-118,2.

医学信息

1006-1959

访问量0
|
下载量0
段落导航相关论文